Skip mediastinal nodal metastases in the IIIA/N2 non-small cell lung cancer

被引:0
|
作者
Illic, N.
Petricevic, A.
Arar, D.
Kotarac, S.
Banovic, J.
Frieta Ilic, N.
Tripkovic, A.
Ercegovic, M.
机构
[1] Univ Surg Hosp Split, Dept Thorac Surg, Split, Croatia
[2] Clin Hosp Split, Pulmol Dept, Split, Croatia
[3] Clin Hosp Split, Dept Oncol, Split, Croatia
来源
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:328 / 328
页数:1
相关论文
共 50 条
  • [21] Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?
    Pages, P. -B.
    Pforr, A.
    Delpy, J. -P.
    Abou Hanna, H.
    Bernard, A.
    REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (05) : 485 - 492
  • [22] SURVIVAL OF PATIENTS WITH UNSUSPECTED N2 (STAGE IIIA) NON-SMALL CELL LUNG CANCER
    Park, Chang Kwon
    Lee, Deok Heon
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S883 - S883
  • [23] Brain metastases in patients with stage N2 non-small cell lung cancer
    Lowrie, C.
    McCully, E.
    Ansel, S.
    McLoone, P.
    Mohammed, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S69 - S69
  • [24] Perspectives on the effect of nodal downstaging and its implication of the role of surgery in stage IIIA (N2) non-small cell lung cancer
    Martin, Linda W.
    Mehran, Reza J.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : E646 - E652
  • [25] Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer
    Yoshino, I
    Yokoyama, H
    Yano, T
    Ueda, T
    Takai, E
    Mizutani, K
    Asoh, H
    Ichinose, Y
    ANNALS OF THORACIC SURGERY, 1996, 62 (04): : 1021 - 1025
  • [26] Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC)
    Elias, AD
    Skarin, AT
    Leong, T
    Mentzer, S
    Strauss, G
    Lynch, T
    Shulman, L
    Jacobs, C
    Abner, A
    Baldini, EH
    Frei, E
    Sugarbaker, DJ
    LUNG CANCER, 1997, 17 (01) : 147 - 161
  • [27] Trimodal therapy and surgical approaches in stage IIIA/N2 non-small cell lung cancer
    Hu, Pin-Ching
    Huang, Jing-Yang
    Cheng, Ya-Fu
    Cheng, Ching-Yuan
    Huang, Chang-Lun
    Hung, Wei-Heng
    Wang, Bing-Yen
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] MANAGEMENT OF N2 NON-SMALL CELL LUNG CANCER
    Shetty, Preethi S.
    Mankar, Hemant
    Pramesh, C. S.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 152 (05): : 1463 - 1464
  • [29] Risk factors of brain metastases as initial failure in completely resected stage IIIA(N2) non-small cell lung cancer
    Zhang, Qin
    Cai, Xu-Wei
    Feng, Wen
    Yu, Wen
    Fu, Xiao-Long
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [30] Risk Factors of Brain Metastases as Initial Failure for Completely Resected Stage IIIA (N2) Non-Small Cell Lung Cancer
    Zhang, Q.
    Fu, X.
    Feng, W.
    Cai, X. W.
    Yu, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E398 - E399